|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-03
|
$245,762
|
$245,762
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
(OTHER FUNCTIONS) PRODUCE AND PUBLISH BBI JOURNAL SUPPLEMENT
|
N02CA120268-000
|
$35,034
|
$35,034
|
CHARKIN, TOBY
|
ELSEVIER INC
|
|
5-hydroxymethylcytosine in human cancer
|
1R01CA160965-01A1
|
$348,600
|
$174,300
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A causal role for asymmetric cell division defects in glioma initiation
|
1R01CA164746-01
|
$320,588
|
$320,588
|
Petritsch, Claudia
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas
|
ZIABC011367
|
$16,858
|
$16,858
|
Kreisl, Teri
|
CCR (NCI)
|
|
A pilot study of statin therapy and risk of malignant glioma
|
7K07CA127468-05
|
$135,513
|
$135,513
|
Lai, Rose
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Predictive Prognostic Model for Glioblastoma Multiforme
|
1R01CA157553-01A1
|
$446,607
|
$446,607
|
BUI, ALEX
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
|
5R01CA136774-04
|
$310,970
|
$310,970
|
Pieper, Russell
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
5R01CA055577-19
|
$256,139
|
$51,228
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Triple-armed Oncolytic Virus for Glioblastoma
|
N43CO120061-000
|
$199,904
|
$199,904
|
MULVEY, MATTHEW
|
BENEVIR BIOPHARM, INC.
|
|
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
|
5R01CA151522-03
|
$252,801
|
$252,801
|
Hjelmeland, Anita
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
$62,924
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$309,002
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
ADAM 17 and glioma-tumor progression and treatment
|
5R01CA129446-04
|
$291,849
|
$291,849
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
|
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
|
5R01CA134844-04
|
$312,186
|
$312,186
|
MITCHELL, DUANE
|
DUKE UNIVERSITY
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
3R01CA125244-03S1
|
$49,970
|
$49,970
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
5R01CA125244-03
|
$685,920
|
$685,920
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Adult Brain Tumor Consortium (ABTC)
|
5U01CA137443-04
|
$1,818,177
|
$1,818,177
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-04
|
$335,446
|
$335,446
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Advanced Training in Surgical Oncology
|
5T32CA009535-25
|
$319,187
|
$63,837
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AEG-1: Novel Gene Involved in Malignant Glioma
|
5R01CA134721-04
|
$300,907
|
$300,907
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Aging and Primary Central Nervous System Tumors
|
ZIABC011348
|
$62,975
|
$62,975
|
Iwamoto, Fabio
|
CCR (NCI)
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-03
|
$316,002
|
$316,002
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Allergic Condition Susceptibility Polymorphisms and Glioma Risk
|
5R01CA122163-05
|
$488,884
|
$488,884
|
SCHWARTZBAUM, JUDITH
|
OHIO STATE UNIVERSITY
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S1
|
$723,662
|
$723,662
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U10CA080098-14
|
$3,138,212
|
$3,138,212
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Integrated CT-based Image-Guided Neurosurgical System
|
5R44CA112966-03
|
$738,678
|
$738,678
|
Li, Senhu
|
XORAN TECHNOLOGIES, INC.
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
2R01CA129541-06
|
$322,525
|
$161,263
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Analysis of active and inactive EGFR conformations
|
5R01CA112552-07
|
$234,554
|
$117,277
|
FERGUSON, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-10
|
$330,583
|
$66,117
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Anticancer Agents from Plant- and Lichen-Associated Fungi of the Sonoran Desert
|
4R01CA090265-08
|
$263,534
|
$65,884
|
GUNATILAKA, LESLIE
|
UNIVERSITY OF ARIZONA
|
|
Anticancer Drug Pharmacology in Very Young Children
|
1R01CA154619-01A1
|
$433,475
|
$433,475
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Apical-basal polarity signaling in glioblastoma
|
3R01CA149258-03S1
|
$54,631
|
$54,631
|
Ghosh, Sourav
|
UNIVERSITY OF ARIZONA
|
|
Apical-basal polarity signaling in glioblastoma
|
5R01CA149258-03
|
$310,465
|
$310,465
|
Ghosh, Sourav
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$4,315
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$118,614
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)
|
1R01CA170592-01
|
$512,621
|
$512,621
|
LIGON, KEITH
|
DANA-FARBER CANCER INSTITUTE
|
|
Astatine And Iodine Radiolabeled Monoclonal Antibodies
|
5R01CA042324-26
|
$472,247
|
$472,247
|
ZALUTSKY, MICHAEL
|
DUKE UNIVERSITY
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$35,307
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
ATP-Dependent Chromatin Remodeling in Human Malignancy
|
1R01CA163915-01A1
|
$326,459
|
$81,615
|
Crabtree, Gerald
|
STANFORD UNIVERSITY
|
|
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
|
5P01CA087634-09
|
$1,357,823
|
$488,816
|
Meyer, Charles
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Autophagy in Brain Tumor
|
5R01CA135038-04
|
$323,791
|
$323,791
|
YANG, JIN-MING
|
PENNSYLVANIA STATE UNIVERSITY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
$730,499
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$4,862
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$7,458
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$13,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$528,256
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$2,800
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$15,437
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
Total relevant funding to Brain for this search: $171,301,440
|